PFE | Pfizer Inc.

54.95 0.00 (0.00%)

PFE Price Profile

Open Price:


Close Price:


High Price:


Low Price:


Prev. Close:


50 Day MA:


52 Week High:


52 Week Low:


Trading volume:


Market cap:


PE Ratio (TTM):


Diluted EPS (TTM):


Quarterly Revenue

growth YOY: 1.344

Quarterly Earnings

growth YOY: 4.468

Pfizer Inc. (PFE) Company Profile

Pfizer is an American multinational pharmaceutical company that develops, manufactures, and sells healthcare products globally. The pharmaceutical company was founded in 1849 by Charles F. Erhart and Charles Pfizer in New York. The Company went public in June 1942, and it trades on the New York Stock Exchange (NYSE) under the ticker PFE. 

Pfizer’s product portfolio includes medicines and vaccines. The Company manages operations through two business segments:

  • Pfizer Innovative Health (IH) segment focuses on developing and commercializing medicines and vaccines globally. The IH therapeutic sector comprises internal medicine, vaccines, oncology, inflammation and immunology, rare diseases, and consumer healthcare.
  • Pfizer Essential Health (EH) segment includes legacy brands, branded generics, generic sterile injectable products, biosimilars, and infusion systems. Furthermore, EH also consists of a research and development (R&D) organization and its contract manufacturing business.

Common Pfizer brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq, and Viagra. 

Pfizer’s main competitors 

  • Merck & Co.
  • Novartis AG
  • Eli Lilly & Co
  • Bristol Myers Squibb
  • Johnson & Johnson

Key Pfizer milestones 

In December 2020, Pfizer’s coronavirus vaccine was the first to be approved in the United Kingdom. This is after the company reported an over 95% success rate. 

In 2000, Pfizer acquired Warner-Lambert for $111.8 billion. The deal at the time created the second-largest pharmaceutical company in the world. Warner-Lambert was a Philadelphia drug company known for inventing a tablet-coating.

In 2018, Pfizer signed a deal with the German biotechnology company BioNTech, to conduct joint research and development activities. Under the agreement, Pfizer would assume sole responsibility for further clinical development and commercialization of mRNA-based flu vaccines. The collaborative partnership was credited with the development of the coronavirus vaccine. 

Between 2010 and 2011, Pfizer recorded one of its biggest revenues in history at $65.16 billion and $65.25 billion, respectively. 

Pfizer Frequently Asked Questions

How often does Pfizer pay dividends?

Pfizer pays dividends four times per year, excluding specials. Typically, dividends cover is approximately 2.0.

Has Pfizer split its stock?

In the company’s history, Pfizer has split its stock six times. The 6th split took place on November 17, 2020.

Why is Pfizer successful?

Pfizer’s success is based on continuous research and development as well as long-term planning. Pfizer constantly offers effective medicines in the fight against and prevention of diseases.